Cost optimization Recent European office closures and headcount reductions suggest a cost optimization phase. Opportunities exist to offer streamlined fluidics and optics components with scalable pricing, and to present value through compact, integrated solutions that reduce footprint and maintenance for customers in cost-sensitive markets.

Expansion partner needs Despite closures, ongoing partnerships in proteomics and imaging indicate demand for high-performance optics modules and biocompatible fittings. Target labs and contract manufacturers expanding in proteomics, cytometry or diagnostics may require robust optofluidic paths, modular components, and customized engineering support.

Strategic collaborations Recent collaboration with Quantum-Si on optics modules signals receptivity to co-development. Leverage this by proposing joint development opportunities, faster time-to-market optics, and shared IP strategies to capture next-gen sequencing, proteomics and analytical workflows.

Innovation portfolio Award recognition for BrightLine 2.0 and ongoing launches such as BioTight fittings and Nanopede optical filters underscore a strong R&D cadence. Position product bundles around reliable, low-risk fluidic assemblies and high-performance filters for flow cytometry, sequencing prep, and analytical instrumentation.

Diverse end markets Customer base spans analytical and diagnostic life sciences with applications in flow cytometry, proteomics, and biotech instrumentation. Cross-sell opportunities exist across instrument manufacturers, lab services providers, and academia seeking integrated optofluidic paths, precision fittings, and modular components.